Favezelimab
Modify Date: 2025-08-26 17:29:43
Favezelimab structure
|
Common Name | Favezelimab | ||
|---|---|---|---|---|
| CAS Number | 2231068-83-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FavezelimabFavezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902)[1][2]. |
| Name | Favezelimab |
|---|
| Description | Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |